Trial intelligence / Profile preview

Liraglutide versus sitagliptin for cardiac structure and function in young adults with type 2 diabetes

2012-002422-78Phase 4Completed

Sponsor
University of Leicester
Start
Jul 2013
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide arm with Sitagliptin arm (2 arms). Primary endpoint: Change in left ventricular diastolic dysfunction. Started Jul 2013; status: completed.

02

Drugs

liraglutidesitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2012-002422-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002422-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call